Ziwei Fang
Overview
Explore the profile of Ziwei Fang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
2123
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fang Z, Ma H, Shao H, Dai W, Qu Z, Liu S, et al.
Environ Res
. 2025 Jan;
268:120740.
PMID: 39753158
The pressing necessity to mitigate climate change and decrease greenhouse gas emissions has driven the advancement of heterostructure-based photocatalysts for effective CO₂ reduction. This study introduces a novel heterojunction photocatalyst...
2.
Fang Z, Kong W, Zhao Z, Sun W, Xu G, Clark L, et al.
Front Pharmacol
. 2024 Dec;
15:1507042.
PMID: 39697544
Introduction: Endometrial cancer is the most common malignancy of the female reproductive system in the United States. is a versatile, nutrient-dense, low-calorie vegetable that contains various bioactive metabolites that have...
3.
Huang Y, Zhang Y, Yang N, Qian Z, Fang Z, Zeng L, et al.
Geroscience
. 2024 Dec;
PMID: 39653972
Fibroblast growth factor 21 (FGF21) is a key regulator of metabolism and cardiovascular health. However, its upregulation in aging and age-related disorders suggests the presence of FGF21 resistance. This study...
4.
Zhang Y, Zhao Y, Fang Z, Liu J, Xia C, Hou Z, et al.
Nanophotonics
. 2024 Dec;
13(6):891-899.
PMID: 39634366
The multicore fiber amplifier, as a key component in spatial division multiplexing (SDM) communication systems, presents higher technical difficulty compared to traditional multi-channel single core fiber amplifiers, which has sparked...
5.
Zhao Z, Wang J, Kong W, Fang Z, Coleman M, Milne G, et al.
Gynecol Oncol
. 2024 Apr;
186:126-136.
PMID: 38669767
Objective: Overweight/obesity is the strongest risk factor for endometrial cancer (EC), and weight management can reduce that risk and improve survival. We aimed to establish the differential benefits of intermittent...
6.
Qian Z, Huang Y, Zhang Y, Yang N, Fang Z, Zhang C, et al.
Front Genet
. 2024 Feb;
15:1353908.
PMID: 38415056
Physical weakness and cardiovascular risk increase significantly with age, but the underlying biological mechanisms remain largely unknown. This study aims to reveal the causal effect of circulating metabolites on frailty,...
7.
Zhao Z, Wang J, Kong W, Fang Z, Coleman M, Milne G, et al.
bioRxiv
. 2024 Feb;
PMID: 38370796
Objective: Overweight/obesity is the strongest risk factor for endometrial cancer (EC), and weight management can reduce that risk and improve survival. We aimed to establish the differential abilities of intermittent...
8.
Xu G, Zhao Z, Wysham W, Roque D, Fang Z, Sun W, et al.
Front Oncol
. 2023 Aug;
13:1219923.
PMID: 37601677
Introduction: Among all cancers, endometrial cancer is most strongly associated with obesity, with more than 65% of endometrial cancers attributable to obesity and being overweight. Fatty acid synthase (FAS), a...
9.
Fan Y, Wang J, Fang Z, Pierce S, West L, Staley A, et al.
Front Oncol
. 2022 Apr;
12:789450.
PMID: 35372029
ONC201 is a promising first-in-class small molecule that has been reported to have anti-neoplastic activity in various types of cancer through activation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) as...
10.
Tucker K, Yin Y, Staley S, Zhao Z, Fang Z, Fan Y, et al.
Am J Cancer Res
. 2022 Mar;
12(2):521-536.
PMID: 35261784
ONC206, a dopamine receptor D2 (DRD2) antagonist and imipridone, is a chemically modified derivative of ONC201. Recently, ONC206 and other imipridones were identified as activators of the mitochondrial protease ClpP,...